marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Bio-Rad Laboratories Cash Flow 2011-2024 | BIO
Annual Cash Flow Bio-Rad Laboratories
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
375 M | 194 M | 669 M | 585 M | 458 M | 285 M | 104 M | 216 M | 186 M | 273 M | 169 M | 266 M | 263 M |
Depreciation & Amortization |
146 M | 137 M | 138 M | 139 M | 134 M | 138 M | 149 M | 143 M | 132 M | 150 M | 147 M | 130 M | 121 M |
Accounts Payables |
145 M | 135 M | 142 M | 139 M | 107 M | 122 M | 135 M | 133 M | 122 M | 129 M | 149 M | 131 M | 129 M |
Accounts Receivables |
489 M | 495 M | 424 M | 419 M | 393 M | 392 M | 465 M | 372 M | 391 M | 378 M | 423 M | 399 M | - |
Total Inventories |
781 M | 719 M | 572 M | 622 M | 554 M | 584 M | 595 M | 525 M | 490 M | 471 M | 501 M | 448 M | 434 M |
All numbers in USD currency
Quarterly Cash Flow Bio-Rad Laboratories
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 69.8 M | - | - | 98.1 M | - | 104 M | - | 50.5 M | - | 499 M | - | 114 M | - | 291 M | 155 M | 62.8 M | - | 298 M | 198 M | 42.9 M | - | 180 M | 118 M | 40.3 M | - | 34.8 M | 6.3 M | -56.2 M | - | 121 M | 69.7 M | -7.45 M | - | 150 M | 68 M | 29.4 M | - | 233 M | 142 M | 65.6 M | - | 98.6 M | 43.8 M | 24 M | - | 180 M | 109 M | 35.3 M | - | 181 M | 130 M | 19.8 M |
Depreciation & Amortization |
5.3 M | 5.3 M | 5.5 M | 6.2 M | 5.9 M | 6 M | - | 6.2 M | 6.3 M | 6.3 M | - | 7.3 M | 7.2 M | 7.2 M | - | 7.2 M | 7.2 M | 33.6 M | - | 6 M | 5.6 M | 32.9 M | - | 104 M | 68.7 M | 34.3 M | - | 106 M | 70.7 M | 33.7 M | - | 110 M | 71.7 M | 34.1 M | - | 98 M | 64.4 M | 32.3 M | - | 110 M | 73 M | 36.7 M | - | 105 M | 68.2 M | 33.3 M | - | 94.9 M | 62.7 M | 31.1 M | - | 88.1 M | 57.7 M | 28.1 M |
Accounts Payables |
122 M | 127 M | 103 M | 112 M | 150 M | 161 M | 135 M | 143 M | - | 161 M | 142 M | 136 M | 133 M | 138 M | 139 M | 139 M | 139 M | 139 M | 107 M | 107 M | - | - | 122 M | - | - | - | 135 M | - | - | - | 133 M | - | - | - | 122 M | - | - | - | 129 M | 127 M | 125 M | 131 M | 149 M | 149 M | 149 M | 149 M | 131 M | 131 M | 131 M | 131 M | 129 M | 129 M | 129 M | 129 M |
Accounts Receivables |
462 M | 446 M | 445 M | 457 M | 492 M | 498 M | 495 M | 432 M | - | 464 M | 424 M | 418 M | 399 M | 408 M | 419 M | 419 M | 419 M | 419 M | 393 M | 393 M | 393 M | 393 M | 392 M | 392 M | 392 M | 392 M | 465 M | 465 M | 465 M | 465 M | 372 M | 372 M | 372 M | 372 M | 391 M | 391 M | 391 M | 391 M | 378 M | 378 M | 378 M | 378 M | 423 M | 423 M | 423 M | 423 M | 399 M | 399 M | 399 M | 399 M | 399 M | 375 M | 395 M | 389 M |
Total Inventories |
804 M | 804 M | 783 M | 776 M | 777 M | 753 M | 719 M | 686 M | - | 605 M | 572 M | 589 M | 599 M | 605 M | 622 M | 622 M | 622 M | 622 M | 554 M | 554 M | 554 M | 554 M | 584 M | 584 M | 584 M | 584 M | 595 M | 595 M | 595 M | 595 M | 525 M | 525 M | 525 M | 525 M | 490 M | 490 M | 490 M | 490 M | 471 M | 471 M | 471 M | 471 M | 516 M | 516 M | 501 M | 501 M | 455 M | 455 M | 448 M | 448 M | 434 M | 434 M | 434 M | 434 M |
All numbers in USD currency